Home / Market News / $DRMA

$DRMA news and market catalysts

The 3 most recent market catalysts affecting $DRMA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 0 high impact 2 bullish 0 bearish Biotechnology

Aug 17, 2026 Corporate Catalyst Neutral Impact 75

Dermata Therapeutics Announces $3.4M Private Placement Of 2,293,608 Shares And Warrants Priced At-The-Market At $1.46 Per Share

This private placement is a significant event for Dermata Therapeutics, as it injects $3.4 million into the company, providing much-needed capital for R&D, clinical trials, or gene…

Aug 12, 2026 Corporate Catalyst Bullish Impact 75

Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving?

Dermata Therapeutics' stock experienced a significant pre-market surge despite missing Q2 earnings estimates. The primary catalyst appears to be the announcement of the upcoming la…

Aug 11, 2026 Corporate Catalyst Bullish Impact 65

12 Health Care Stocks Moving In Tuesday's After-Market Session

This filing details the after-market performance of 12 health care stocks, with gains and losses largely attributed to the release of Q2 earnings reports. The immediate impact is s…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.